BioWorld Science

Aug. 20, 2021

View Archived Issues

Bright Minds Biosciences compound reduces seizures in animal models of Dravet syndrome/epilepsy

Read More

Persica completes first stage of clinical trial on PP-353 for low back pain

Read More

Vigil Neuroscience advances TREM2 agonists

Read More

CAR T-cell therapy enters first-in-human trial for hematologic cancers

Read More

Esteve Pharmaceuticals presents new analgesic drugs

Read More

Children's Medical Center patents ALK CAR for melanoma and neuroblastoma

Read More

LP-184 induces tumor growth inhibition in glioblastoma models

Read More

Vyant Bio to collaborate with Cyclica on discovery of treatments for CDKL5 deficiency disorder

Read More

Fate Therapeutics details responses seen in trials of FT-516 and FT-596

Read More

Phase II data show improvements in GM2 gangliosidosis with IB-1001

Read More

IBI-362 demonstrates body weight-lowering effect in phase I trial

Read More

Coeptis Therapeutics and VyGen-Bio to codevelop products targeting CD38 cancers

Read More

AAV9 gene therapy enters clinical development for Canavan disease

Read More

CRISPR Therapeutics AG presents new CAR Tcells for immuno-oncology

Read More

Rare gene variants increase zoonotic H7N9 susceptibility

Read More

[11C]MTP-38 first use in human PET studies shows promise for neurological disorders

Read More

VEGFC mRNA-LNP platform induces formation of a functional lymphatic network and reverses lymphedema

Read More

IL-26 is involved in malignant pleural effusion and associated with poor prognosis

Read More